the lobsterpot< – edition 38

Malayming Higher

We spend a lot of time talking about small shifts in tolerance being a big deal. So it’s even more important to highlight big shifts in thought. If you’re caught in Malaysia with enough cannabis you can be given the death penalty, which is genuinely mad. Thankfully they’re starting to look up and are exploring the idea of a legal medical market. Nice work guys.

‍

‍

Splash That Cash

The UK government’s business innovation agency, innovatively named Innovate UK, has recently allocated just shy of a cool half mill to Canna Group who are working on a way to make CBD-HQ extraction commercially viable. It goes a long way in showing that there’s a growing appetite for funding in the space.

‍

Una Revolución Legislativa

We may have featured him last week, but Colombian President Gustavo Petro is making further waves as he rolls out his ideas for drug legislation in the country. He’s only suggesting, at the moment, but there’s potential for domestic cannabis companies to not need a licence to operate which could create a more competitive market.

‍

‍

Class Is In Session

Following legalisation of medical cannabis in Spain, many organisations are now playing catch up so that they can best help patients. The Spanish General Counsel of Official Colleges of Physicians have plans to train doctors in how to effectively prescribe medical cannabis. This is a big step because education is crucial in building better patient outcomes.

‍

Well Ya Don’t Say(!)

A Gallup study held in the US found that the vast majority of Americans who had tried cannabis viewed it positively. It’s interesting to think about how important a first cannabis experience is, and how impactful it can be in shaping your view of a substance or the people that consume it.

‍

Making Good Ground

While the federal legalisation of cannabis in America continues to elude proponents of the industry, there is progress being made in the world of psychedelic therapies. The government now sees FDA approval of some psychedelic therapies within the next two years.

‍